Advances in treatment of acute ischemic stroke

Current Neurology and Neuroscience Reports

Volumn 6, Issue 1, 2006, Pages 28-32

  Linfante, Italo ^a   Akkawi, Nabil M ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; IODINATED CONTRAST MEDIUM; PLACEBO; PLASMINOGEN ACTIVATOR; PROUROKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

AUSTRALIA; BARTHEL INDEX; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CANADA; CATHETERIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EMBOLECTOMY; EMERGENCY CARE; ENDOVASCULAR SURGERY; EUROPEAN UNION; FIBRINOLYTIC THERAPY; GLASGOW COMA SCALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL DECISION MAKING; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; RANKIN SCALE; REPERFUSION; REVIEW; RHEOLYTIC THROMBECTOMY; STENT; SURGICAL EQUIPMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; UNITED STATES;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; FIBRINOLYTIC AGENTS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES; URINARY PLASMINOGEN ACTIVATOR;

EID: 31544450243     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-996-0006-y     Document Type: Review

References (35)

1. Heart Disease and Stroke Statistics - 2005 Update. http://www.americanheart.org/presenter.jhtml?identifier=3000090. Accessed October 4, 2005.
2. Baird AE, Warach S: Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998, 18:583-609.
3. Kidwell CS, Alger JR, Saver JL: Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal MRI. Stroke 2003, 34:2729-2735.
4. Sunshine JL, Tarr RW, Lanzieri CF, et al.: Hyperacute stroke: ultrafast MR imaging to triage patients before therapy. Radiology 1999, 212:352-332.
5. Shih LC, Saver JL, Alger JR, et al.: Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003, 34:1425-1430.
6. Schellinger PD, Fiebach JB, Jansen O, et al.: Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol 2001, 49:460-469.
7. Linfante I, Llinas RH, Caplan LR, et al.: MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke 1999, 30:2263-2267.
8. Linfante I: Can MRI reliably detect hyperacute Intracerebral Hemorrhage? Ask the medical student. Stroke 2004, 35:506-507.
9. Le Bihan D, Breton E, Lallemand D, et al.: MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986, 161:401-407.
10. Warach S, Chien D, Li W, et al.: Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 1992, 42:1717-1723.
11. Edelman RR, Johnson K, Buxton R, et al.: MR of hemorrhage: a new approach. Am J Neuroradiol 1986, 7:751-756.
12. Fiebach JB, Schellinger PD, Gass A, et al.: Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004, 35:502-506.
13. Kidwell CS, Chalela JA, Saver JL, et al.: Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004, 292:1823-1830.
14. Sims JR, Rordorf G, Smith EE, et al.: Arterial occlusion revealed by CT angiography predicts NIH stroke score and acute outcomes after IV tPA treatment. Am J Neuroradiol 2005, 26:246-251.
15. Ezzeddine MA, Lev MH, McDonald CT, et al.: CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke. Stroke 2002, 33:959-966.
16. Eastwood JD, Lev MH, Wintermark M, et al.: Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. Am J Neuroradiol 2003, 24:1869-1875.
17. Alexandrov AV, Molina CA, Grotta JC, et al., CLOTBUST Investigators: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004, 351:2170-2178.
18. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333:1581-1587.
19. Frankel MR, Morgenstern LB, Kwiatkowski T, et al.: Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology 2000, 55:952-959.
20. Reed SD, Cramer SC, Blough DK, et al.: Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001, 32:1832-1840.
21. Johnston SC, Fung LH, Gillum LA, et al.: Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke 2001, 32:1061-1068.
22. Rubiera M, Alvarez-Sabin J, Ribo M, et al.: Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 2005, 36:1452-1456.
23. Linfante I, Llinas RH, Selim M, et al.: Clinical and vascular outcome in ICA versus MCA occlusions after IV tPA. Stroke 2002, 33:2066-2071.
24. Gonner F, Remonda L, Mattle H, et al.: Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998, 29:1894-1900.
25. Qureshi AI: Endovascular treatment of cerebrovascular diseases and intracranial neoplasms. Lancet 2004, 363:804-813.
26. Molina CA, Saver JL: Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke 2005, 36:2311-2320.
27. Qureshi AI, Siddiqui AM, Suri MF, et al.: Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002, 51:1319-1327.
28. Qureshi AI, Ali Z, Suri MF, et al.: Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001, 49:41-48.
29. Deshmukh VR, Fiorella DJ, Albuquerque FC, et al.: Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/ IIIa inhibitors as adjunctive therapy. Neurosurgery 2005, 56:46-54.
30. Furlan AJ, Higashida RT, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism JAMA 1999, 282:2003-2011.
31. Lewandowski CA, Frankel M, Tomsick TA, et al.: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999, 30:2598-2605.
32. IMS Study Investigators: Combined intravenous and intraarterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004, 35:904-911.
33. Smith WS, Sung G, Starkman S, et al.; MERCI Trial Investigators: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36:1432-1438.
34. Berlis A, Lutsep H, Barnwell S, et al.: Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004, 35:1112-1116.
35. Fisher M, Albers GW, Donnan GA, et al.: Stroke Therapy Academic Industry Roundtable IV. Enhancing the development and approval of acute stroke therapies: stroke therapy academic industry roundtable. Stroke 2005, 36:1808-1813.